You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH)擬向小熊貓藥業轉讓4個藥品品種所有權
格隆匯 02-04 16:16

格隆匯2月4日丨方盛製藥(603998.SH)公佈,2021年2月3日,公司及全資子公司海南博大分別與公司控股子公司小熊貓藥業簽訂《品種轉讓協議》,決定分別以人民幣395萬元轉讓“小兒喜食咀嚼片”、“黃柏膠囊”、“枸櫞酸鉍鉀顆粒”3個藥品品種的所有權、以人民幣5萬元轉讓“炎立消膠囊”藥品品種的所有權。

本次藥品轉讓有利於公司及控股子公司小熊貓藥業整合上下游資源,憑藉“上市許可持有人制度”大力推進“生產+銷售”一體化的運營模式進程。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account